Literature DB >> 25651048

Hemorrhagic complications in pediatric cardiac patients on extracorporeal membrane oxygenation: an analysis of the Extracorporeal Life Support Organization Registry.

David K Werho1, Sara K Pasquali, Sunkyung Yu, Janet Donohue, Gail M Annich, Ravi R Thiagarajan, Jennifer C Hirsch-Romano, Michael G Gaies.   

Abstract

OBJECTIVES: To determine the prevalence of and risk factors for hemorrhagic complications in children with cardiac disease requiring extracorporeal membrane oxygenation.
DESIGN: Retrospective review of the Extracorporeal Life Support Organization Registry (2002-2013).
SETTING: Participating Extracorporeal Life Support Organization centers. PATIENTS: Patients less than 18 years old on extracorporeal membrane oxygenation.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Of 21,845 patients requiring extracorporeal membrane oxygenation during the study period, 8,905 (41%) had cardiac disease, and 79% of whom (6,995) had cardiac surgery. Hemorrhagic complications occurred in 8,480 patients (39% of overall cohort), with higher rates in cardiac versus noncardiac patients (49% vs 32%; p < 0.0001) related to cannulation and surgical site bleeding. Cardiac surgical patients had higher rates of hemorrhage compared with cardiac medical patients (57% vs 38%; p < 0.0001), and cardiac patients with hemorrhage had higher extracorporeal membrane oxygenation mortality compared with those without (42% vs 22% in medical patients and 34% vs 20% in surgical patients; both p < 0.0001). In multivariable analysis in both the cardiac medical and surgical groups, hemorrhage risk was higher in children greater than 1 year old and in patients with longer extracorporeal membrane oxygenation duration. Additional independent risk factors for hemorrhage in cardiac surgical patients included pre-extracorporeal membrane oxygenation mediastinal exploration (odds ratio, 3.6; 95% CI, 2.1-6.3), Society of Thoracic Surgeons morbidity category 4-5 (odds ratio, 1.2; 95% CI, 1.03-1.5), cannulation less than 24 hours after surgery (odds ratio, 1.6; 95% CI, 1.3-1.9), and longer cardiopulmonary bypass time (≥ 282 min [upper quartile]; odds ratio, 1.5; 95% CI, 1.3-1.9).
CONCLUSIONS: In this large, multicenter analysis, hemorrhagic complications occurred in nearly half of children with heart disease on extracorporeal membrane oxygenation and were associated with a significant mortality risk. Several factors were associated with hemorrhagic complications in cardiac surgical patients including pre-extracorporeal membrane oxygenation mediastinal exploration, greater surgical complexity, early postoperative cannulation, and longer bypass times. Whether these risks can be mitigated by modifying or delaying systemic anticoagulation requires further investigation.

Entities:  

Mesh:

Year:  2015        PMID: 25651048      PMCID: PMC4668708          DOI: 10.1097/PCC.0000000000000345

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  26 in total

1.  Extracorporeal membrane oxygenation circulatory support after congenital cardiac surgery.

Authors:  Yasuyuki Suzuki; Sanae Yamauchi; Kazuyuki Daitoku; Kozo Fukui; Ikou Fukuda
Journal:  ASAIO J       Date:  2009 Jan-Feb       Impact factor: 2.872

Review 2.  Anticoagulation and coagulation management for ECMO.

Authors:  William C Oliver
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2009-09

3.  Predictors of intracranial hemorrhage during neonatal extracorporeal membrane oxygenation.

Authors:  G E Hardart; J C Fackler
Journal:  J Pediatr       Date:  1999-02       Impact factor: 4.406

4.  Intravascular volume administration: a contributing risk factor for intracranial hemorrhage during extracorporeal membrane oxygenation?

Authors:  Amerik C de Mol; Luella C Gerrits; Arno F J van Heijst; Huub Straatman; Frans H J M van der Staak; Kian D Liem
Journal:  Pediatrics       Date:  2008-05-05       Impact factor: 7.124

5.  Risk factors for bleeding in pediatric post-cardiotomy patients requiring ECLS.

Authors:  Kathryn Nardell; Gail M Annich; Jennifer C Hirsch; Cathe Fahrner; Pat Brownlee; Karen King; Geoffrey M Fleming; Robert J Gajarski
Journal:  Perfusion       Date:  2009-09-18       Impact factor: 1.972

6.  Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey.

Authors:  Melania M Bembea; Gail Annich; Peter Rycus; Gary Oldenburg; Ivor Berkowitz; Peter Pronovost
Journal:  Pediatr Crit Care Med       Date:  2013-02       Impact factor: 3.624

7.  Extracorporeal Life Support Registry Report 2008: neonatal and pediatric cardiac cases.

Authors:  Nikkole M Haines; Peter T Rycus; Joseph B Zwischenberger; Robert H Bartlett; Akif Undar
Journal:  ASAIO J       Date:  2009 Jan-Feb       Impact factor: 2.872

8.  Neurological injury after extracorporeal membrane oxygenation use to aid pediatric cardiopulmonary resuscitation.

Authors:  Cindy S Barrett; Susan L Bratton; Joshua W Salvin; Peter C Laussen; Peter T Rycus; Ravi R Thiagarajan
Journal:  Pediatr Crit Care Med       Date:  2009-07       Impact factor: 3.624

9.  Pediatric and neonatal extracorporeal membrane oxygenation: does center volume impact mortality?*.

Authors:  Carrie L Freeman; Tellen D Bennett; T Charles Casper; Gitte Y Larsen; Ania Hubbard; Jacob Wilkes; Susan L Bratton
Journal:  Crit Care Med       Date:  2014-03       Impact factor: 7.598

10.  The association of carotid artery cannulation and neurologic injury in pediatric patients supported with venoarterial extracorporeal membrane oxygenation*.

Authors:  Sarah A Teele; Joshua W Salvin; Cindy S Barrett; Peter T Rycus; Francis Fynn-Thompson; Peter C Laussen; Ravi R Thiagarajan
Journal:  Pediatr Crit Care Med       Date:  2014-05       Impact factor: 3.624

View more
  19 in total

1.  Epidemiology of Stroke in Pediatric Cardiac Surgical Patients Supported With Extracorporeal Membrane Oxygenation.

Authors:  David K Werho; Sara K Pasquali; Sunkyung Yu; Janet Donohue; Gail M Annich; Ravi R Thiagarajan; Jennifer C Hirsch-Romano; Michael Gaies
Journal:  Ann Thorac Surg       Date:  2015-08-20       Impact factor: 4.330

Review 2.  Anticoagulation Therapy during Extracorporeal Membrane Oxygenator Support in Pediatric Patients.

Authors:  Hwa Jin Cho; Do Wan Kim; Gwan Sic Kim; In Seok Jeong
Journal:  Chonnam Med J       Date:  2017-05-25

3.  Efficacy of Flow Monitoring During ECMO.

Authors:  Aditya Badheka; Sara E Stucker; Joseph W Turek; Madhavan L Raghavan
Journal:  ASAIO J       Date:  2017 Jul/Aug       Impact factor: 2.872

4.  Coagulopathy Characterized by Rotational Thromboelastometry in a Porcine Pediatric ECMO Model.

Authors:  Christopher R Reed; Desiree Bonadonna; Jeffrey Everitt; Victoria Robinson; James Otto; Elisabeth T Tracy
Journal:  J Extra Corpor Technol       Date:  2020-09

5.  Comparing Percutaneous to Open Access for Extracorporeal Membrane Oxygenation in Pediatric Respiratory Failure.

Authors:  Sarah B Cairo; Mary Arbuthnot; Laura Boomer; Michael W Dingeldein; Alexander Feliz; Samir Gadepalli; Christopher R Newton; Pramod Puligandla; Robert Ricca; Peter Rycus; Adam M Vogel; Guan Yu; Ziqiang Chen; David H Rothstein
Journal:  Pediatr Crit Care Med       Date:  2018-10       Impact factor: 3.624

6.  Use of Thromboelastography to Predict Thrombotic Complications in Pediatric and Neonatal Extracorporeal Membranous Oxygenation.

Authors:  Natalie Henderson; Janice E Sullivan; John Myers; Terri Wells; Aaron Calhoun; John Berkenbosch; Deanna Todd Tzanetos
Journal:  J Extra Corpor Technol       Date:  2018-09

7.  Single-center experience of extracorporeal membrane oxygenation mainly anticoagulated with nafamostat mesilate.

Authors:  Woosik Han; Jin San Bok; Hyun Jin Cho; Jae Hyeon Yu; Myung Hoon Na; Shinkwang Kang; Min-Woong Kang
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

8.  Factors Associated with Bleeding and Thrombosis in Children Receiving Extracorporeal Membrane Oxygenation.

Authors:  Heidi J Dalton; Ron Reeder; Pamela Garcia-Filion; Richard Holubkov; Robert A Berg; Athena Zuppa; Frank W Moler; Thomas Shanley; Murray M Pollack; Christopher Newth; John Berger; David Wessel; Joseph Carcillo; Michael Bell; Sabrina Heidemann; Kathleen L Meert; Richard Harrison; Allan Doctor; Robert F Tamburro; J Michael Dean; Tammara Jenkins; Carol Nicholson
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

9.  Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation.

Authors:  Dawid L Staudacher; Paul M Biever; Christoph Benk; Ingo Ahrens; Christoph Bode; Tobias Wengenmayer
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

10.  Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation.

Authors:  Cécile Aubron; Joris DePuydt; François Belon; Michael Bailey; Matthieu Schmidt; Jayne Sheldrake; Deirdre Murphy; Carlos Scheinkestel; D Jamie Cooper; Gilles Capellier; Vincent Pellegrino; David Pilcher; Zoe McQuilten
Journal:  Ann Intensive Care       Date:  2016-10-06       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.